Fundraising FoxGilde Healthcare
Venture capitalUtrecht · Seed–Late Stage · 25 people tracked
Also known as GILDE HEALTHCARE PARTNERS B.V.
Find your way into Gilde Healthcare
Sign up to see every warm intro you have to Gilde Healthcare
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Gilde Healthcare team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Gilde Healthcare invests in impactful companies addressing healthcare and climate challenges through three strategies. Its Healthcare Private Equity fund backs profitable businesses that support the healthcare sector, including providers, medical product suppliers, and service companies. The Healthcare Venture & Growth fund targets disruptive companies in medtech, digital health, medical instruments, and therapeutics. The Climate Solutions fund invests in profitable companies focused on energy transition, biodiversity, and waste & pollution. The firm combines operating and financial expertise across a transatlantic team and integrates ESG and measurable impact into its investment approach.
Source: firm website, verified Sep 29, 2026.
Team · 25 people
from the firm's website & public directories
What they invest in
from 35 of 39 portfolio companiesHealthtech ×26Medical Devices ×23Biotech ×15Hardware ×8Digital Health ×6AI & Machine Learning ×3Deep Tech ×3SaaS ×2
HQs:United States×17Netherlands×3United Kingdom×2Denmark×1Ireland×1
Investments · 39 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 42024 · 62023 · 22022 · 12021 · 12020 · 42019 · 22018 · 12017 · 12014 · 12012 · 126 dated
Draupnir Bio develops targeted protein degradation therapies using sortilin-based lysosome targeting chimeras to clear extracellular and membrane-bound protein aggregates in proteinopathies.
BiotechDeep TechMedical DevicesCopenhagen, DK
Simon Glerup(Professor)inCamilla Gustafsen(Professor)inPeder Søndergaard Madsen(Professor)Peter Seeberger(Professor)
Co-investorsInkefMC Healthcare VenturesNovo Holdings
Levicept is a company in the life sciences sector with backing from prominent healthcare and pharmaceutical investors including Medicxi, Pfizer Ventures, Gilde Healthcare, and Advent Life Sciences.
BiotechHealthtechMedical Devices
Simon Westbrook(Founder and CSO)in
Co-investorsAdvent Life SciencesIndex VenturesMedicxiPfizer VenturesPfizer Venture InvestmentsRedwood Ventures
Purespring develops genetic therapies targeting podocytes to treat renal diseases through its proprietary GlomThera platform.
BiotechDigital HealthHealthtechMedical Devices
Moin Saleem(Co-founder & Chief Scientific Advisor)in
Co-investorsSofinnova PartnersForbionAdvent Life SciencesBritish Patient Capital
Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease.
HealthtechMedical DevicesWayne, US
Bruce J. Shook(President and CEO)Monica Klos(Executive Officer)inNeil Hattangadi(Director)inPeter Schneider(Director)Mark Garcia(Director)Dennis W. Wahr(Director)
Co-investorsNew Enterprise Associates (NEA)Lightstone VenturesVensana Capital415 Capital
VS3 Medical is a medical device company developing the VS3 Medical Stent System, an investigational neurovascular implant designed to treat symptomatic venous sinus stenosis within the dural venous sinus anatomy.
HardwareHealthtechMedical Devices
Co-investorsAPERTURE Venture PartnersUS Venture Partners
.406 Ventures is an early-stage venture capital firm that partners with founders in healthcare, data and AI, and cybersecurity to help grow their companies.
Maria Cirino(Founder)in
Co-investorsGrandBanks CapitalAlleyCorpCVS Health VenturesSandbox Clinical Ventures
HealthtechWakefield, US
Tim A. Fischell(Executive Officer, Director)inKate Rumrill(Executive Officer, Director)Lisa Mastromattei(Executive Officer)Ronald D Bache(Executive Officer, Director)Vartan E. Ghazarossian(Executive Officer, Director)David R. Fischell(Director)
Co-investorsMichigan Capital NetworkBioStar VenturesMAF
Eagle Pharmaceuticals develops and commercializes specialty pharmaceutical products for acute care and oncology, including injectable medications for procedural sedation, chemotherapy, lymphomas, and malignant hyperthermia management.
BiotechHealthtechMedical DevicesIndianapolis, US
Co-investorsF-Prime Capital
Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need.
BiotechMedical Devices
Co-investorsVida VenturesHealthCapJeito CapitalNovo HoldingsOrbiMedPontifax Venture Capital+3 more
Agendia develops genomic technology and diagnostic tests for breast cancer patients.
AI & Machine LearningBiotechDigital HealthMedical DevicesIrvine, US
Laura van 't Veer(Co-founder)inRené Bernards(Co-founder)inProf. Laura van 't Veer, PhD(Chief Research Officer, Co-founder)Prof. Dr. René Bernards, PhD(Co-Founder and Scientific Advisor)Mark R. Straley(CEO)in
Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).
BiotechHealthtechMedical DevicesAustin, US
Adam Berman(Executive Officer, Director)inJacob Kriegel(Executive Officer, Director)Avni Patel(Executive Officer, Director)Christopher Alex Arevalos(Executive Officer, Director)Albertien Greijdanus(Executive Officer, Director)
BoardGeoff Pardo(Director)in
Co-investorsBroadview VenturesRiverVest Venture PartnersTMC Venture FundCadence Healthcare VenturesGilmartin Capital LLCOmega Funds+2 more
Amphista Therapeutics develops next-generation targeted protein degradation (TPD) medicines using its proprietary Targeted Glue technology, which is engineered to selectively trigger the destruction of disease-causing proteins.
BiotechCambridge, GB
Louise Modis(Chief Executive Officer)inMartin Pass(Chief Development Officer)inGiles Brown(Executive VP Drug Discovery)in
Co-investorsAdvent Life SciencesNovartis Venture FundSV Health InvestorsDementia Discovery FundEuropean Investment FundForbion+2 more
Argá Medtech is developing a non-thermal cardiac ablation system based on a proprietary Pulsed Field Ablation (PFA) technology using sine wave energy and a proprietary catheter to treat atrial fibrillation and other heart arrhythmias.
HardwareHealthtechMedical Devices
Co-investorsAdvent Life SciencesHigh Tech GruenderfondsEarlybird Venture CapitalHTGF
Axonics Modulation, now part of Boston Scientific, develops medical devices in the field of neuromodulation therapies for patients.
HealthtechMedical Devices
Raymond Cohenin
Co-investorsAPERTURE Venture PartnersLongitude CapitalAdvent Life SciencesNeomed Management
Boston Scientific develops medical devices and technologies used by healthcare professionals to treat patients across a range of conditions.
HealthtechMedical DevicesIrvine, US
Michael Williamson(Executive Officer)Dan L. Dearen(Executive Officer)inRaymond Cohen(Executive Officer, Director)in
BoardDarren Cai(Director)Raphael Wisniewski(Director)Erik Amble(Director)
Co-investorsAdvent Life SciencesAndera PartnersLongitude Capital
Big Health develops digital treatments and care programs for mental health conditions, including cognitive behavioral therapy-based solutions for insomnia and other mental health issues.
Digital HealthHealthtechMental Health
Peter Hames(Founder)inColin Espie(Founder)
Co-investors.406 Ventures515 VenturesAlleyCorpBlue Venture FundsIndex VenturesInnovation Global Capital+9 more
Elmsford, US
Jonathan Taqqu(Executive Officer, Director)
BoardJohn Lee(Director)
Co-investorsHealthy Ventures.406 VenturesAlleyCorpCVS Health VenturesSandbox Clinical Ventures
Endovascular Engineering develops clot removal technologies targeting venous thromboembolism.
Medical Devices
Co-investors415 CapitalNorwest Venture PartnersS3 VenturesPanakes Partners
FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care.
Digital HealthHardwareMedical DevicesDublin, IE
Co-investorsAndera PartnersGimvIreland Strategic Investment FundLightstone VenturesLongitude CapitalNew Enterprise Associates (NEA)+5 more
GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources that is implanted during brain tumor removal surgery to deliver targeted radiation to remaining cancer cells.
BiotechHealthtechMedical Devices
David G. Brachman, MD, FASTRO(Co-Founder and Chief Technology Officer)Heyoung McBride, MD, MS, FASTRO(Co-Founder)Peter Nakaji, MD(Co-Founder)inEmad Youssef, MD(Co-Founder)Theresa Thomas, MS, CCRC(Co-Founder)Per Langoe(Chief Executive Officer)in
Co-investorsAccelmed PartnersBlueStone Venture PartnersEvidity Health CapitalFemHealth VenturesMedTech Venture PartnersMVM Life Science Partners+1 more
Inari Medical develops mechanical thrombectomy devices for treating venous thromboembolism conditions, including pulmonary embolism, deep vein thrombosis, in-stent thrombosis, and arteriovenous fistula thrombosis.
HardwareHealthtechMedical DevicesIrvine, US
William H. Hoffman(Executive Officer, Director)inRobert Rosenbluth(Executive Officer, Director)
BoardDonald Milder(Director)Kirk Nielsen(Director)inJonathan Root(Director)inBrian Cox(Director)
Co-investorsUS Venture PartnersVensana CapitalVersant Ventures
Developed lightweight portable oxygen concentrators; acquired by ResMed.
HealthtechAustin, US
John B. Rush(Executive Officer, Director)Daniel Jensen(Executive Officer)
BoardGeoff Pardo(Director)inStephen M. Salmon(Director)Richard Lin(Director)Roderick A. Young(Director)
Co-investorsLatterell Venture Partners
LAVA develops the Gammabody platform, which generates bispecific antibodies that activate gamma-delta T cells to treat cancer by directing immune cells to tumors and triggering anti-cancer immune responses.
AI & Machine LearningBiotechHealthtechMedical Devices
Ton AdanginHans van der Vliet(Head of Innovation)inSteve Hurly(Chief Executive Officer)Oxana Polyakova(Chief Scientific Officer)in
Co-investorsMRL Ventures FundSanofi VenturesYsios CapitalNovo HoldingsREDMILE
LUMICKS develops life science research tools that measure and apply forces around biological interactions to link structural and 'omics analysis to functional outcomes at the molecular and cellular level.
BiotechDeep TechHardwareMedical Devices
Andrea(Co-founder & Chief Scientific Officer)Gerrit(Co-founder & Director of Product Management and Marketing)Hugo(CEO)Edmee(Chief Financial Officer)Hannah(HR Director)
Co-investorsLauxera Capital PartnersSoftBank Vision FundEuropean Investment BankIrving InvestorsPura Vida InvestmentsT. Rowe Price
Mainstay provides an AI-powered platform that enables higher education institutions to engage students through proactive, personalized coaching and messaging.
AI & Machine LearningEdTechHR TechSaaSArlington, US
Andrew Magliozzi(Founder)inKirk Daulerio(Co-Founder, Vice President, Community)in
BoardKEVIN TALBOT(Director)
Co-investorsAlumni VenturesBisk VenturesEastward Capital PartnersFundersClubK Street CapitalMichelson 20MM Foundation+12 more
Irish company developing an advanced neurostimulation device.
HealthtechPlymouth, US
Dan Sachs(Director)Peter Crosby(Executive Officer, Director)inJason Hannonin
BoardManus Rogan(Director)inAntoine Papiernik(Director)in
Co-investorsFountain Healthcare PartnersIreland Strategic Investment FundSeventure PartnersSofinnova PartnersViking GlobalAlly Bridge Group+1 more
HealthtechFremont, US
Anton Clifford(Executive Officer)inJames Leech(Executive Officer)inChristopher Gleason(Executive Officer)inKevin K. Sidow(Executive Officer, Director)
BoardJoshua Makower(Director)Shahzad Malik(Director)in
Co-investorsLightstone VenturesNew Enterprise Associates (NEA)Runway Growth CapitalAdvent Life SciencesGBS Venture Partners Ltd.Morgenthaler+1 more
Noema Pharma develops a late-stage portfolio of oral small molecule therapeutics for people with neurological and related disorders, targeting both orphan and larger indications with significant unmet medical needs.
BiotechHealthtechMedical Devices
Ilise Lombardo(Chief Executive Officer)inVolker Knappertz(Executive Vice President of Research & Development)inMichael Samar(Chief Financial Officer)inRob Lasser(Chief Medical Officer)in
Co-investorsBioMedPartnersJeito CapitalRoche Venture FundSofinnova PartnersEQTEQT Life Sciences+2 more
Okami Medical develops the LOBO vascular occlusion system, an occluder built on high-density, small-pore HDBRAID technology for fast arterial occlusion in the peripheral vasculature, along with SENDERO microcatheters and delivery catheters.
BiotechHardwareHealthtechMedical DevicesAliso Viejo, US
Brian J. Cox(Manager)inRhonda Robb(Executive Officer, Director)inRobert Rosenbluth(Director)
BoardDonald Milder(Director)Jonathan Root(Director)inPaul Lubock(Director)
Co-investorsUS Venture PartnersVensana Capital
Performation provides business intelligence, data analytics, and monitoring software and consulting for the healthcare sector, covering areas such as care registration, capacity planning, and real-world monitoring.
Data & InfrastructureDigital HealthHealthtechSaaS
App to improve mental health and insomnia
Co-investorsIndex VenturesKaiser Permanente VenturesOctopus VenturesSamsung Next
Spire Health provides continuous respiratory monitoring devices used by pulmonologists and patients to track lung disease.
HealthtechWellness & FitnessSan Francisco, US
Neema Moraveji(Chief Scientist)inRustam Lalkaka(Head of Product)Adil Majid(User Experience Designer)Jonathan Palley(CEO)Francesco Mosconi(Chief Data Officer)Ben Yule(CTO)
Co-investorsScrum VenturesY CombinatorCFJ InvestmentsDN CapitalPacific Health VenturesRock Health Capital+2 more
Symeres provides pharmaceutical quality management systems, drug discovery and development services, and contract manufacturing support for biotech and pharma companies.
BiotechDeep TechEnterprise SoftwareHealthtechNetherlands, NL
Henning Steinhagen(Chief Executive Officer (CEO))inJurgen Berendsen(Chief Financial Officer (CFO))in
Co-investorsKeensight Capital
Tagworks Pharmaceuticals develops cancer therapies using its Click-to-Release platform, a chemical reaction that activates antibody-drug conjugates (ADCs), masked immunomodulators, and other prodrugs on-target while deactivating radioimmunotherapies off-target.
BiotechHealthtechMedical DevicesNijmegen, NL
Co-investorsBifLightstone VenturesNew Enterprise Associates (NEA)Novartis Venture FundYsios CapitalClarus Ventures+1 more
Urotronic develops drug-coated balloons for interventional urology, including the Optilume products for treating benign prostatic hyperplasia (BPH) and urethral strictures.
HealthtechMedical DevicesPlymouth, US
Junfeng Wang(Director)David Perry(Executive Officer, Director)Tan Ching(Director)Hui Hu(Director, Promoter)Lixiao Wang(Director, Promoter)Doug Kohrs(Director)
Co-investorsHM Venture PartnersEnterprise IrelandIreland Strategic Investment FundLegend CapitalLightstone VenturesMVM Life Science Partners+1 more
Vapotherm manufactures high-velocity therapy devices for respiratory distress treatment across patient populations.
HardwareHealthtechMedical DevicesExeter, US
JOSEPH ARMY(Executive Officer, Director)JOHN LANDRY(Executive Officer)in
BoardANTHONY ARNERICH(Director)JASON LETTMAN(Director)GEOFF PARDO(Director)inSAMUEL BRASCH(Director)
Co-investorsCross Creek AdvisorsKaiser Permanente VenturesQuestMark Partners3x5 PartnersMorgenthaler
Withings makes connected health devices and an accompanying app ecosystem that lets consumers track and improve health metrics.
ConsumerDigital HealthHardware
Cédric Hutchings(Founder)Fred Potter(Founder)Éric Carreel(Founder)
Co-investors2050360 CapitalAdelieBpifranceIdinvest Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
GT Medical TechnologiesONWARD Medical
Exits · 2
2 acquisitions · showing 1Inova Labsacq. by ResMed
Portfolio news
latest coverage across their companiesSymeres · symeres.com · Jan 14, 2026
Okami Medical · finsmes.com · Nov 20, 2025
Purespring · purespringtx.com · Oct 4, 2025
Frequently asked questions
- How many investments has Gilde Healthcare made?
- Gilde Healthcare has 39 tracked investments, 2 of which have exited, including 8 dated in the last 24 months.
- What stage does Gilde Healthcare invest at?
- Gilde Healthcare invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Gilde Healthcare's typical check size?
- Gilde Healthcare typically writes checks of $1.1M – $55M.
- What sectors does Gilde Healthcare focus on?
- Gilde Healthcare focuses on Biotech, Climate Tech, Digital Health, Energy, Healthtech, Impact & Social Good, Medical Devices.
- Where is Gilde Healthcare located?
- Gilde Healthcare is headquartered in Utrecht, NL.
- Does Gilde Healthcare lead rounds?
- Gilde Healthcare typically participates in rounds rather than leading them.
Media · Podcasts & interviews
featuring the teamJanke Dittmer, Gilde Healthcare Partners
Invest Europe · Janke Dittmer
Investment Strategy in Health Tech Industry - Janke Dittmer, Gilde Healthcare Partners
Tech Tour · Janke Dittmer
Images
Similar investors
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
RA Capital Management is a healthcare and planetary health investment firm that founds, funds, and scales companies using scientific diligence, multi-stage capital, and hands-on operational support.
OUP (Osage University Partners) is a venture firm that invests in science-driven startups commercializing deep technology innovations emerging from university and breakthrough research.